Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Syndax Pharmaceuticals (SNDX) Gross Profit (2024 - 2026)

Syndax Pharmaceuticals has reported Gross Profit over the past 3 years, most recently at $53.0 million for Q1 2026.

  • For Q1 2026, Gross Profit rose 176.76% year-over-year to $53.0 million; the TTM value through Mar 2026 reached $186.4 million, up 391.78%, while the annual FY2025 figure was $138.6 million, 639.06% up from the prior year.
  • Gross Profit for Q1 2026 was $53.0 million at Syndax Pharmaceuticals, down from $59.1 million in the prior quarter.
  • Over five years, Gross Profit peaked at $59.1 million in Q4 2025 and troughed at $2.8 million in Q4 2024.
  • A 3-year average of $28.0 million and a median of $27.9 million in 2025 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: skyrocketed 2050.36% in 2025 and later skyrocketed 176.76% in 2026.
  • Year by year, Gross Profit stood at $2.8 million in 2024, then skyrocketed by 2050.36% to $59.1 million in 2025, then dropped by 10.34% to $53.0 million in 2026.
  • Business Quant data shows Gross Profit for SNDX at $53.0 million in Q1 2026, $59.1 million in Q4 2025, and $37.6 million in Q3 2025.